Related Issues
From the Journals
Possible obesity effect detected in cancer death rates
As with heart disease, declines in mortality for some cancers seem to be affected by the obesity epidemic.
Perspectives
Five reasons why medical meetings will never be the same
Feature
Survey: Hydroxychloroquine use fairly common in COVID-19
News
FDA reiterates hydroxychloroquine limitations for COVID-19
An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial...
From the Journals
Angiotensin drugs and COVID-19: More reassuring data
From the Journals
Hydroxychloroquine ineffective for COVID-19, VA study suggests
The retrospective study, which included
From the Journals
Signature STEMI sign may be less diagnostic in the COVID-19 age
Latest News
COVID-19: U.S. cardiology groups reaffirm continued use of RAAS-active drugs
Experts give ACE inhibitors and ARBs, cornerstones of cardiology therapy, a thumbs up despite a hypothetical adverse COVID-19 effect.
Latest News
COVID-19: Older patients with cancer especially vulnerable
Expert advises diligence in screening cancer patients and commonsense preventative measures.
From the Journals
Death from unintentional injury is higher in cancer patients
More initiatives are needed to help recognize patients at risk of death from unintentional injury, according to researchers.
From the Journals
World Cancer Day survey exposes ‘glaring inequities’
The survey revealed a lack of cancer awareness among people with lower socioeconomic status and educational attainment.